Fabio Guolo

24PUBLICATIONS
120CO-AUTHORS
Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Infant and child healthNeonatologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Mar 07, 2026
Like a bolt from the blue: the trauma of facing acute leukemia and lymphoma diagnosis and its clinical implications.

Fabio Guolo, Paola Del Sette, Francesca Riccardi

|Feb 24, 2026
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Raffaele Palmieri, Fabio Guolo, Luana Fianchi

|Feb 11, 2026
Intermediate doses cytarabine after induction with CPX-351 for patients with secondary AML: safety and efficacy.

Salvatore Perrone, Andrea Corbingi, Calogero Vetro

|Dec 05, 2025
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Raffaele Palmieri, Fabio Guolo, Luana Fianchi

|Dec 04, 2025
Correction: Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia.

Calogero Vetro, Bruno Garibaldi, Francesco Grimaldi

|Oct 27, 2025
Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia.

Calogero Vetro, Bruno Garibaldi, Francesco Grimaldi

Pageof 4

Frequent Collaborators

11 joint publications

Paola Minetto

7 joint publications

Marco Cerrano

7 joint publications

Livio Pagano

7 joint publications

Patrizia Chiusolo